Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment
by American College of PhysiciansCredit: CC0 Public DomainA post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk profile may more precisely characterize
Updated on: April 02,2024
11
Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment
by American College of PhysiciansCredit: CC0 Public DomainA post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk profile may more precisely characterize
Updated on:April 02,2024
11